5 Antidotes to Diagnostic Uncertainty
April 13, 2017
An array of new tools, perspectives, and guidelines to help navigate the gray areas have been reported in recent days.
Prostate Cancer
Patient Goals Should Figure Prominently in Tx Discussions
October 31, 2016
Wanted: Physicians who will interact with patients the way a good financial counselor would.
Prostate Cancer Treatments Abundant, Not Perfect
December 8, 2015
A range of options for metastatic castration resistant prostate cancer offer benefits, but impact on survival and sequencing guidance are less than optimal.
No Added Prostate Cancer Risk With Long-term Testosterone Tx
October 12, 2015
Risk does not go up with exposure to testosterone therapy over a 5-year period or according to total testosterone injections.
Safest for Favorable-risk Prostate Cancer: Surveillance
September 15, 2015
The goal is to avoid treating men who don’t need surgery or radiation. A new long-term study points to the potential of surveillance as a treatment option.
Paradox: Asthma Resists Lethal Prostate Cancer
August 24, 2015
Lethal prostate cancer is less—not more—likely to develop in patients with asthma. The Health Professionals Follow-up Study answers key questions about why.
Low Testosterone May Indicate Prostate Cancer Progression
May 8, 2014
Low testosterone levels may indicate disease worsening in men diagnosed with low-risk prostate cancer who are being evaluated by active surveillance, according to a new study.
Cialis Fails to Prevent Erectile Dysfunction From Prostate Cancer Treatment
May 1, 2014
In a recent study, the drug tadalafil (Cialis) did not improve erectile function in men undergoing radiation therapy for prostate cancer.
Commentary on the USPF's Recommendations on PSA Testing
October 20, 2011
A video series from James Mohler of Rosweel Park Cancer Institute on PSA testing in the wake of changing guidelines from the US Preventive Task Force.
Video: Who's at Risk for Prostate Cancer?
October 20, 2011
James Mohler, MD, Roswell Park Cancer Institue, discusses risk factors for prostate cancer.
